TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36004732

Group type: EXPERIMENTAL
Intervention: Early adenotonsillectomy (AT) within 2 months
Number of subjects: 190

Group type: COMPARATOR
Intervention: Routine adenotonsillectomy (AT) after 12 months
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Both early and routine AT
Number of subjects: 190
Study: 33937960

Group type: EXPERIMENTAL
Intervention: Del Nido cardioplegia
Number of subjects: 80

Group type: COMPARATOR
Intervention: Blood cardioplegia
Number of subjects: 80
Study: 32208231

Group type: EXPERIMENTAL
Intervention: Exposure and response prevention (ERP) treatment
Number of subjects: 50
Study: 35194648

Group type: EXPERIMENTAL
Intervention: Ledipasvir/Sofosbuvir (once-daily)
Number of subjects: 58
Study: 34487346

Group type: EXPERIMENTAL
Intervention: Heat treatment (Imm+H) using pulsed shortwave diathermy for 2 hours daily for 10 days
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham treatment (Imm)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 21
Study: 34847453

Group type: EXPERIMENTAL
Intervention: Nature-based program (2 hours, twice a week for three consecutive weeks)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no nature-based program)
Number of subjects: 45
Study: 32199446

Group type: EXPERIMENTAL
Intervention: Epinephrine autoinjectors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prefilled syringes
Number of subjects: 0
Study: 33888247

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure treatment
Number of subjects: 8828

Group type: COMPARATOR
Intervention: Standard systolic blood pressure treatment
Number of subjects: 8828
Study: 36563830

Group type: EXPERIMENTAL
Intervention: Tumescent local anesthesia (TLA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 70
Study: 33389770

Group type: EXPERIMENTAL
Intervention: SSB behavioural intervention
Number of subjects: 100
Study: 32945875

Group type: EXPERIMENTAL
Intervention: Combined intervention (motivational enhancement therapy and cognitive behavioral therapy, 6 in-person sessions of 1 hour each and 3 optional group sessions)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Brief intervention (similar components as combined intervention but consisting of 2 shorter in-person sessions and 2 telephone sessions)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Brief intervention
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Combined intervention
Number of subjects: 440
Study: 32915099

Group type: EXPERIMENTAL
Intervention: L‐DRSEQ‐SRA in the non‐drinking group
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: L‐DRSEQ‐SRA
Number of subjects: 406
Study: 33978699

Group type: EXPERIMENTAL
Intervention: Therapist-guided internet-delivered cognitive behavioral therapy (ICBT) for 10 weeks.
Number of subjects: 103

Group type: COMPARATOR
Intervention: Therapist-guided internet-delivered supportive therapy (ISUPPORT) for 10 weeks.
Number of subjects: 103

Group type: COMPARATOR
Intervention: Cost-effectiveness analysis for ICBT vs ISUPPORT.
Number of subjects: 103
Study: 32584279

Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Viscoelastic bite wafer
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Chewing gum
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 105
Study: 36468512

Group type: EXPERIMENTAL
Intervention: Parietene ProGrip self‐fixing mesh (PG)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Lightweight standard mesh (LS)
Number of subjects: 141
Study: 33560877

Group type: EXPERIMENTAL
Intervention: PTR plus chemotherapy
Number of subjects: 165

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 165
Study: 36498519

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (100 micrograms)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Single‐shot femoral nerve block (SSFNB)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine
Number of subjects: 52
Study: 34656032

Group type: EXPERIMENTAL
Intervention: Multimodal nutritional intervention (dietetic counselling, individual nutrition plan, protein-rich drinks)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Multimodal nutritional intervention
Number of subjects: 191
Study: 33211860

Group type: EXPERIMENTAL
Intervention: CR6261 (50 mg/kg)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 33568600

Group type: EXPERIMENTAL
Intervention: Retrievable cement/screw-retained design (RCSRD) metal copings
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cement-retained (CR) metal copings
Number of subjects: 20
Study: 35311678

Group type: EXPERIMENTAL
Intervention: PROGRESS website
Number of subjects: 217
Study: 33156201

Group type: COMPARATOR
Intervention: Zuspan regimen (4‐g IV loading dose, then a 1‐g/h infusion)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Alternate regimen (6‐g IV loading dose, then a 2‐g/h infusion)
Number of subjects: 37
Study: 36227672

Group type: EXPERIMENTAL
Intervention: Cupping moxibustion combined with oral montmorillonite powder
Number of subjects: 51

Group type: COMPARATOR
Intervention: Oral montmorillonite powder
Number of subjects: 51
Study: 34266454

Group type: EXPERIMENTAL
Intervention: COVID-19 ARDS
Number of subjects: 310

Group type: COMPARATOR
Intervention: non-COVID-19 ARDS
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: COVID-19 ARDS with heat and moisture exchangers
Number of subjects: 310
Study: 34955301

Group type: EXPERIMENTAL
Intervention: CIMPALL intervention (five-session, 540 min, multidomain, audiovisually aided, therapist-facilitated)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 36
Study: 33039994

Group type: EXPERIMENTAL
Intervention: Early Parenting Acceptance and Commitment Therapy (Early PACT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 60
Study: 36004553

Group type: EXPERIMENTAL
Intervention: Mobile application in addition to standard follow-up care
Number of subjects: 670

Group type: COMPARATOR
Intervention: Standard follow-up care
Number of subjects: 670
Study: 33577139

Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation (DBS) after electrode implantation
Number of subjects: 14

Group type: COMPARATOR
Intervention: No stimulation (blinded subgroup)
Number of subjects: 14
Study: 34144680

Group type: EXPERIMENTAL
Intervention: Low APTI (73,000 kPa·s)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High APTI (73,000 × 1.5 kPa·s)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both APTI stimuli
Number of subjects: 10
Study: 35307775

Group type: EXPERIMENTAL
Intervention: Peer-based dyadic intervention
Number of subjects: 34
Study: 33140989

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) during the procedure
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no VR)
Number of subjects: 30
Study: 34643781

Group type: EXPERIMENTAL
Intervention: CT-based fractal dimension analysis
Number of subjects: 215

Group type: COMPARATOR
Intervention: nCRT (neoadjuvant chemoradiation therapy)
Number of subjects: 215
Study: 35717156

Group type: EXPERIMENTAL
Intervention: Group Interpersonal Psychotherapy (IPT-G) delivered by community health workers (CHWs)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Treatment as usual (wait-listed group)
Number of subjects: 24
Study: 35255916

Group type: EXPERIMENTAL
Intervention: EMF exposure (mimicking mobile phone base stations) during provocation sessions
Number of subjects: 150

Group type: COMPARATOR
Intervention: Sham sessions (no EMF exposure)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Perceived EMF exposure in control group
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Perceived EMF exposure in IEI‐EMF group
Number of subjects: 150
Study: 32924315

Group type: EXPERIMENTAL
Intervention: Angong Niuhuang pill (ANP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine postoperative nursing
Number of subjects: 80
Study: 32571245

Group type: EXPERIMENTAL
Intervention: Radiomics features extracted from preoperative contrast-enhanced chest CT
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Radiomics signature based on preoperative CT
Number of subjects: 300
Study: 35294283

Group type: EXPERIMENTAL
Intervention: Fast Iterative Restarted Networks (FIRENETs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deterministic training algorithm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized training algorithm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 33872070

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg once every 3 weeks for up to 35 cycles)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Chemotherapy (platinum-based)
Number of subjects: 305
Study: 34991464

Group type: EXPERIMENTAL
Intervention: Innovative endoscopic oropharyngeal airway
Number of subjects: 360

Group type: COMPARATOR
Intervention: Conventional mouthpiece
Number of subjects: 360
Study: 32308204

Group type: EXPERIMENTAL
Intervention: Dexamethasone 1 mg once daily for 6 months
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 35485344

Group type: EXPERIMENTAL
Intervention: HBsAg-positive individuals with HBV-DNA ≥2000 IU/mL
Number of subjects: 2052

Group type: COMPARATOR
Intervention: HBsAg-negative individuals
Number of subjects: 2052

Group type: EXPERIMENTAL
Intervention: HBsAg-positive individuals with HBV-DNA <2000 IU/mL
Number of subjects: 2052

Group type: EXPERIMENTAL
Intervention: Overall HIV-positive participants
Number of subjects: 2052
Study: 36322562

Group type: EXPERIMENTAL
Intervention: Reduced Nicotine Content (RNC) research cigarettes (nicotine content reduced to 0.2 mg over 18 weeks)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Reduced Nicotine Content (RNC) research cigarettes
Number of subjects: 188

Group type: COMPARATOR
Intervention: Usual Nicotine Content (UNC) research cigarettes (11.6 mg nicotine/cigarette)
Number of subjects: 188
Study: 33817812

Group type: EXPERIMENTAL
Intervention: Xenogenic collagen matrix (CMX)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Connective tissue graft (CTG)
Number of subjects: 125
Study: 35346577

Group type: EXPERIMENTAL
Intervention: Entecavir capsule plus Fuzheng Huayu tablet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Entecavir capsule plus simulant of Fuzheng Huayu
Number of subjects: 0
Study: 33129754

Group type: EXPERIMENTAL
Intervention: Peer support and diabetes self-management education group (PSEG)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional diabetes self-management education-only group
Number of subjects: 58
Study: 32415124

Group type: EXPERIMENTAL
Intervention: Hierarchical phononic crystals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional phononic crystals
Number of subjects: 0
Study: 34171864

Group type: EXPERIMENTAL
Intervention: Ferric derisomaltose 20 mg/kg
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study: 34028974

Group type: EXPERIMENTAL
Intervention: Socket shield technique
Number of subjects: 42

Group type: COMPARATOR
Intervention: Xenograft
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study: 34270409

Group type: EXPERIMENTAL
Intervention: Multidimensional treatment framework (n = 28)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Unrelated education (control group, n = 32)
Number of subjects: 60
Study: 34413518

Group type: EXPERIMENTAL
Intervention: High intensity Facebook advertising campaign
Number of subjects: 6998
Study: 32486890

Group type: EXPERIMENTAL
Intervention: Transoral endoscopic thyroidectomy vestibular approach (TOETVA)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Unilateral axillobreast approach (UABA)
Number of subjects: 101
Study: 32611377

Group type: EXPERIMENTAL
Intervention: Ilomedin
Number of subjects: 236

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study: 35094079

Group type: EXPERIMENTAL
Intervention: DS injection (25 g/L maltose + 25 g/L sucrose + 7.5 g/L NaCl)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Met injection (5 g/L Met + 7.5 g/L NaCl)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: DS plus Met injection (25 g/L maltose + 25 g/L sucrose + 5 g/L Met + 7.5 g/L NaCl)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Noninjection
Number of subjects: 600
Study: 33593769

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin/piperaquine (DP) treatment
Number of subjects: 640
Study: 35470534

Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy + exergaming
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 60
Study: 34187537

Group type: EXPERIMENTAL
Intervention: Decompressive craniectomy (DC)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Craniotomy
Number of subjects: 120
Study: 35256315

Group type: EXPERIMENTAL
Intervention: Intervention group (patients diagnosed by intervention-trained clinicians)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (patients diagnosed by non-intervention-trained clinicians)
Number of subjects: 56
Study: 33472172

Group type: EXPERIMENTAL
Intervention: Anserine 500 mg per day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 33518626

Group type: EXPERIMENTAL
Intervention: KM-248 measles component (n = 172)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Control measles vaccine (n = 85)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: KM-248
Number of subjects: 178
Study: 35671133

Group type: EXPERIMENTAL
Intervention: Divided Attention + Positive Memory Reframing (DA + PMR)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Positive Memory Reframing (PMR)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 41
Study: 33781209

Group type: EXPERIMENTAL
Intervention: eptinezumab
Number of subjects: 2867

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2867
Study: 32148226

Group type: EXPERIMENTAL
Intervention: AMV+IntelliCycle ventilation mode
Number of subjects: 80
Study: 34821140

Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 61

Group type: COMPARATOR
Intervention: Sham needling
Number of subjects: 61
Study: 33773476

Group type: EXPERIMENTAL
Intervention: Concentrated and targeted fact-based instructional intervention
Number of subjects: 8376

Group type: EXPERIMENTAL
Intervention: Longer instructional intervention with scientific concepts
Number of subjects: 8376

Group type: COMPARATOR
Intervention: Control
Number of subjects: 8376
Study: 35034502

Group type: EXPERIMENTAL
Intervention: Cabozantinib plus atezolizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Second novel hormone therapy (NHT)
Number of subjects: 0
Study: 32450928

Group type: EXPERIMENTAL
Intervention: Trial-based cognitive therapy (TBCT)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Prolonged exposure (PE)
Number of subjects: 95
Study: 36141585

Group type: EXPERIMENTAL
Intervention: Physical Activity, Nutrition, and Body Image Intervention (6 interactive sessions over 3 months)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control Group (no intervention)
Number of subjects: 138
Study: 33355792

Group type: EXPERIMENTAL
Intervention: WeChat group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Leaflet group
Number of subjects: 80
Study: 35768985

Group type: EXPERIMENTAL
Intervention: ESPB + fentanyl based intravenous patient‐controlled analgesia (IV‐PCA)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (fentanyl based IV‐PCA only)
Number of subjects: 58
Study: 32558951

Group type: EXPERIMENTAL
Intervention: ACL reconstruction surgery
Number of subjects: 14
Study: 36448621

Group type: EXPERIMENTAL
Intervention: Standard BP lowering treatment
Number of subjects: 2348

Group type: COMPARATOR
Intervention: Intensive BP lowering treatment
Number of subjects: 2348
Study: 35989252

Group type: EXPERIMENTAL
Intervention: 500-mg MXR tablet manufactured by Merck Pharmaceuticals Manufacturing (Jiangsu) Co.
Number of subjects: 54

Group type: COMPARATOR
Intervention: 500-mg MXR tablet manufactured by Merck KGaA
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both products under fed condition
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both products under fasted condition
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both products
Number of subjects: 54
Study: 34246202

Group type: EXPERIMENTAL
Intervention: Training in abdominal pain (AP)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Training in loss of consciousness (LOC)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Training in either symptom (AP or LOC)
Number of subjects: 285
Study: 35218559

Group type: EXPERIMENTAL
Intervention: Terbutaline (4 mg × day−1, n = 13)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (n = 8)
Number of subjects: 21
Study: 33983557

Group type: EXPERIMENTAL
Intervention: Configural frequency analysis (CFA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard log-linear modeling
Number of subjects: 0
Study: 32228710

Group type: EXPERIMENTAL
Intervention: Haploidentical donor transplantation (HIDT)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Matched sibling donor transplantation (MSDT)
Number of subjects: 208
Study: 35882530

Group type: EXPERIMENTAL
Intervention: Neuropsychiatric Inventory-Questionnaire (NPI-Q)
Number of subjects: 318
Study: 33975366

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (10 1-minute bouts with 30 s recovery)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Whole-body vibration with lower-body blood flow restriction (10 cycles of 110 mmHg inflation with 30 s deflation during recovery)
Number of subjects: 10
Study: 32027205

Group type: EXPERIMENTAL
Intervention: Prolance type lancet
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Medlance Plus type lancet
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Acti-Lance type lancet
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: MediSafe Solo type lancet
Number of subjects: 100
Study: 33930234

Group type: EXPERIMENTAL
Intervention: Listening to instrumental classical music 20 minutes before the procedure
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Listening to instrumental classical music during the procedure
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no music before or during the procedure)
Number of subjects: 80
Study: 33727898

Group type: EXPERIMENTAL
Intervention: Preconception healthcare knowledge
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Housewives
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Education level of at least college
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: No history of neonatal death
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Use of family planning methods
Number of subjects: 522
Study: 32951715

Group type: EXPERIMENTAL
Intervention: Melatonin 6 mg daily, 1 hour before bedtime for 12 weeks
Number of subjects: 45
Study: 33220071

Group type: EXPERIMENTAL
Intervention: FAS/PFAS group
Number of subjects: 64

Group type: COMPARATOR
Intervention: HE group
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 64
Study: 33137591

Group type: EXPERIMENTAL
Intervention: PragmaCom training program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive control group
Number of subjects: 0
Study: 35120408

Group type: EXPERIMENTAL
Intervention: 38% silver diamine fluoride (SDF) applied semiannually (twice, at a 6-month interval)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Restorative treatment (RT)
Number of subjects: 98
Study: 33690249

Group type: EXPERIMENTAL
Intervention: Biofeedback-guided pelvic floor muscle training (EMG-BF)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Biofeedback-guided pelvic floor muscle training with extracorporeal magnetic innervation (EMG-BF+ExMI)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 51
Study: 35800160

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 64
Study: 32720198

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33316579

Group type: EXPERIMENTAL
Intervention: generic inhibitory control training (ICT)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: food-specific inhibitory control training (ICT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 100
Study: 33272309

Group type: EXPERIMENTAL
Intervention: Propolis supplementation (300 mg Iranian green propolis extract) three times a day for 2 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (300 mg microcrystalline cellulose) three times a day for 2 weeks
Number of subjects: 80
Study: 36282537

Group type: EXPERIMENTAL
Intervention: risankizumab 150 mg
Number of subjects: 444

Group type: COMPARATOR
Intervention: risankizumab 150 mg (after switching from placebo)
Number of subjects: 444
Study: 35691250

Group type: EXPERIMENTAL
Intervention: Chemotherapy with gonadotropin‐releasing hormone analogs (GnRHa)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 330
Study: 34024594

Group type: EXPERIMENTAL
Intervention: Pooling three soil samples in Pinus and Quercus stands
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pooling six soil samples in mixed stands
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Increasing sample pools in monospecific-stands
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sample pool size in mixed-stands
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Three samples in Mediterranean pure stands
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Six samples in mixed stands
Number of subjects: 60
Study: 34658306

Group type: EXPERIMENTAL
Intervention: Prospective data collection
Number of subjects: 73

Group type: COMPARATOR
Intervention: Retrospective data collection
Number of subjects: 73
Study: 32049319

Group type: EXPERIMENTAL
Intervention: Dose Reduction (DR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 120
Study: 35404990

Group type: EXPERIMENTAL
Intervention: Structured pharmacotherapy optimization intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 32406658

Group type: EXPERIMENTAL
Intervention: Large group (8 mm antrostomy)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Small group (4 mm antrostomy)
Number of subjects: 20